Abstract
Objective
Although the benefit of surgical ablation for atrial fibrillation (AF) performed concomitant to mitral valve surgery is established, whether that performed concomitant to non-mitral cardiac surgery is beneficial remains unclear. In non-mitral, non-left-atriotomy cardiac surgery, the optimal surgical approach for AF remains to be established. Therefore, using the Japan Adult Cardiovascular Surgery Database (JACVSD), we compared 2 surgical ablation procedures [the maze procedure and pulmonary vein isolation (PVI)] performed concomitant to non-mitral cardiac surgery.
Methods
Of 3402 JACVSD patients who had undergone elective non-mitral cardiac surgery by 2012, 1797 (53%) had undergone concomitant PVI, and 1339 (39%) had undergone the maze procedure. To compensate for patient heterogeneity, we conducted a propensity score-matched analysis of 1952 patients who had undergone PVI or the maze procedure (976 patients each).
Results
Operative procedures took significantly longer in the Maze Group. Although postoperative AF occurred in 34.3% of the PVI Group patients and in 31.9% of the Maze Group patients (p = 0.371), the incidence of first-time pacemaker implantation was significantly lower in the PVI Group (1.9 vs. 4.1%, respectively; p = 0.005). There was no significant difference in other morbidities or in operative mortality. Postoperative hospital and ICU stays tended to be longer in the Maze Group.
Conclusions
Our data indicate that surgical ablation of AF concomitant to non-mitral cardiac surgery is beneficial. Furthermore, PVI and the maze procedure appear to be of equal benefit in this context, except that the maze procedure may more frequently result in the need for pacemaker implantation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wong JW, Mak KH. Impact of maze and concomitant mitral valve surgery on clinical outcomes. Ann Thorac Surg. 2006;82:1938–47.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, ACC, AHA Task Force Members, et al. AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;2014(129):e521–643.
Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528–606.
Suwalski P, Suwalski G, Doll N, Majstrak F, Kurowski A, Suwalski KB. Epicardial beating heart “off-pump” ablation of atrial fibrillation in non-mitral valve patients using new irrigated bipolar radiofrequency technology. Ann Thorac Surg. 2006;82:1876–9.
Akpinar B, Sanisoglu I, Guden M, Sagbas E, Caynak B, Bayramoglu Z. Combined off-pump coronary artery bypass grafting surgery and ablative therapy for atrial fibrillation: early and mid-term results. Ann Thorac Surg. 2006;81:1332–7.
Balasubramanian SK, Theologou T, Birdi I. Microwave surgical ablation for atrial fibrillation during off-pump coronary artery surgery using total arterial-Y-grafts: an early experience. Interact Cardiovasc Thorac Surg. 2007;6:447–50.
Groh MA, Binns OA, Burton HG 3rd, Champsaur GL, Ely SW, Johnson AM. Epicardial ultrasonic ablation of atrial fibrillation during concomitant cardiac surgery is a valid option in patients with ischemic heart disease. Circulation. 2008;118(14 Suppl):S78–82.
Cherniavsky A, Kareva Y, Pak I, Rakhmonov S, Pokushalov E, Romanov A, et al. Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders. Interact Cardiovasc Thorac Surg. 2014;18:727–31.
Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg. 2005;27:258–65.
Fukahara K, Miyata H, Motomura N, Doi T, Nagura S, Yoshimura N, et al. Concomitant atrial fibrillation surgery does not increase the risk for mortality and morbidity after coronary artery bypass grafting (abstract). Circulation. 2011;124:A17968.
Ad N, Henry L, Hunt S, Holmes SD. Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery? J Thorac Cardiovasc Surg. 2012;143:936–44.
Yoshida K, Ulfarsson M, Oral H, Crawford T, Good E, Jongnarangsin K, et al. Left atrial pressure and dominant frequency of atrial fibrillation in humans. Heart Rhythm. 2011;8:181–7.
Pokushalov E, Romanov A, Corbucci G, Cherniavsky A, Karaskov A. Benefit of ablation of first diagnosed paroxysmal atrial fibrillation during coronary artery bypass grafting: a pilot study. Eur J Cardiothorac Surg. 2012;41:556–60.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author(s) declared no potential conflict of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Rights and permissions
About this article
Cite this article
Takai, H., Miyata, H., Motomura, N. et al. Comparison of early outcomes of surgical ablation procedures for atrial fibrillation concomitant to non-mitral cardiac surgery: a Japan Adult Cardiovascular Surgery Database study. Gen Thorac Cardiovasc Surg 65, 500–505 (2017). https://doi.org/10.1007/s11748-017-0785-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-017-0785-x